. Trabeculae extend radially and longitudinally, forming a network that comprises most of the myocardial mass, increasing myocardial surface area for gas exchange 1 . Subsequent remodelling and compaction thickens the trabeculae radially until they are indistinguishable from the myocardial wall. Simultaneously, epicardiumderived cells 3 invade the outer compact myocardium and together with ventricular endocardial cells 4 contribute to the coronary vasculature that will support the final growth phase and nourish the adult myocardium 5 . Defective trabecular compaction manifests as left ventricular non-compaction (LVNC) cardiomyopathy, characterized by prominent trabeculations separated by deep intertrabecular recesses in a thin ventricular wall 6, 7 . LVNC is a genetic cardiomyopathy 8 caused by mutations in genes encoding sarcomeric, cytoskeletal and nuclearmembrane proteins, and can manifest as depressed systolic function or as serious complications including systemic embolism, malignant arrhythmias, heart failure and sudden death 9, 10 . LVNC is generally transmitted as an autosomal dominant trait, but the underlying disease mechanisms are poorly understood 7, 11 .
Inactivation of the Notch1 receptor or its effector RBPJK disrupts trabeculation owing to impaired trabecular endocardium and myocardium differentiation and reduced ventricular cardiomyocyte proliferation 12 . Moreover, targeted inactivation of the Notch pathway modulator mind bomb1 (Mib1) in murine myocardium disrupts ventricular chamber maturation leading to LVNC. Mib1 is an E3-ubiquitin ligase that ubiquitylates Notch ligands, triggering their endocytosis and the transendocytosis of the Notch extracellular domain 13 , this last event being essential for generation and release of the Notch intracellular domain 14 (NICD) . Inactivating mutations in human MIB1 have been identified in patients with autosomal dominant familial LVNC (ref. 15) . Thus, the NOTCH pathway plays central roles in ventricular chamber development and LVNC (refs 12,15) , but the signalling elements and underlying regulatory circuitries involved are unresolved.
Endocardial Dll4 and myocardial Jag1 are candidate Notch ligands in the early mouse heart
Using the single-cell-resolution Notch reporter line CBF:H2B-Venus (ref. 16 ), we mapped Notch activation in the developing ventricles 1 in relation to the ligands Dll4 and Jag1. CBF:H2B-Venus was widely expressed in chamber endocardium of embryonic day 9.5 (E9.5) wild-type (WT) CBF:H2B-Venus embryos, and expression was abrogated in RBPJk-and Notch1-targeted mutants ( Fig. 1a and Supplementary Fig. 1a ). Whole-mount staining of E9.5 CBF:H2B-Venus hearts for α-smooth-muscle actin (SMA) and CD31, also known as Pecam1, confirmed endocardial Notch activity (Fig. 1b,b and Supplementary Video 1). At E9.5, Dll4 was preferentially expressed in the endocardium at the base of developing trabeculae, while Jag1 was expressed in trabecular myocardium, both coinciding with sites of CBF:H2B-Venus activity (Fig. 1c-d ) . Amira-3D reconstructions of the early expression patterns of Dll4 ( Supplementary Fig. 1b and Supplementary Data File 1), Jag1 ( Supplementary Fig. 1b and Supplementary Data File 2) and N1ICD ( Supplementary Fig. 1b and Supplementary Data File 3 and refs 12,15) supported these observations. Endocardial Dll4 expression weakened from E12.5 to E15.5 ( Supplementary Fig. 1c ,c ) and Dll4 transcription disappeared by E15.5 but persisted in coronary vessel endothelium ( Supplementary  Fig. 1e ,e ). In contrast, Jag1 expression expanded to the compact myocardium but was weaker than in trabeculae and coronary vessels ( Supplementary Fig. 1d,d ,f,f ,h,h ) whereas Notch activity was detected throughout endocardium and coronary vessel endothelium ( Supplementary Fig. 1g,h ).
Dll4-Notch1 signalling inactivation disrupts trabeculation and coronary vessel formation
We next crossed mice bearing a conditional Dll4 flox allele 17 with the pan-endothelial and pan-endocardial driver lines Tie2-Cre (ref. 18 ) and Nfatc1pan-Cre (ref. 4) . Dll4 flox inactivation with either driver severely disrupted trabeculation ( Fig. 1e-g ) producing a phenotype similar to that of Notch1 inactivation (Fig. 1h,h ). At E9.5, myosin (MF20) and CD31/Pecam1 staining of mutant hearts revealed reductions in compact myocardium thickness (28%) and trabecular length (50%; Fig. 1i ). N1ICD expression was below normal in the ventricular endocardium of E9.5 Dll4 flox ;Nfatc1pan-Cre and Dll4 flox ;Tie2-Cre mutants ( Supplementary Fig. 2a,b) . In Dll4 flox ;Tie2-Cre mutants, Hey2 transcription marked a thin compact myocardium and was reduced in the endocardium ( Supplementary  Fig. 2c ). Mutant embryos also showed reduced EfnB2, Nrg1 and Bmp10 transcription ( Supplementary Fig. 2c ), known to depend on Notch activity 12 .
To determine the role of cardiac Dll4 at later stages, we bred Dll4 flox mice with the driver Cdh5-Cre ERT , active in endocardium and vascular and coronary vessel endothelium 19 . At E15.5, Dll4 flox ;Cdh5-Cre ERT embryos had neck oedema, suggesting circulatory problems ( Supplementary Fig. 3a ,c). Ventricular wall thickness was reduced in Dll4 flox ;Cdh5-Cre ERT mutants ( Supplementary Fig. 3b,d ). Dll4, strongly expressed in WT coronary vasculature ( Supplementary Fig. 3e ,e ), was markedly reduced in mutants ( Supplementary Fig. 3f ,f ). N1ICD was still expressed in Dll4 flox ;Cdh5-Cre ERT chamber endocardium but was almost absent in intramyocardial coronary vessels ( Supplementary  Fig. 3g,h ). Dll4 flox ;Cdh5-Cre ERT mutant hearts showed normal Hey2 expression in compact myocardium ( Supplementary  Fig. 3i ,j ) but the coronary artery endothelial markers HeyL, EfnB2 and Cx40, also known as Gja5, (Supplementary Fig. 3k-p (Fig. 1k) . Gene ontology (GO) classification revealed deregulation of genes involved in cardiovascular development and disease, cell cycle and proliferation, cell death, dilated cardiomyopathy and intercellular pathways ( Fig. 1l and Supplementary Fig. 4a,b) . Dll4 flox ;Tie2-Cre and Dll4 flox ;Nfatc1pan-Cre mutants showed upregulation of the negative regulators of cellular proliferation Cdkn1a (also known as p21), Cdkn1b, Gadd45a, Foxo3, Cbx7, Ccng2, Ndrg1, Myct1 and Runx1 (Fig. 1l) . Consistently, cardiomyocyte proliferation was 42% lower in Dll4 flox ;Nfatc1pan-Cre mutants than in WT counterparts ( Fig. 1m-o) .
The three genotypes showed pronounced downregulation of Gpr126 (Fig. 1l and Supplementary Table 1) , encoding an orphan adhesion G protein-coupled receptor 20 whose inactivation in mice causes hypotrabeculation and ventricular wall thinning 21, 22 . Gpr126 was transcribed in E9.5 WT endocardium and downregulated in Dll4 flox ;Nfatc1pan-Cre mutants ( Fig. 1p-q ) . Cardiac expression of zebrafish gpr126 was abrogated in Notch-deficient mib1 ta52b mutant larvae ( Supplementary Fig. 2d ,e ) and in WT larvae treated with the Notch inhibitor RO4929097 (ref. 23; Supplementary Fig. 2d,d ,f,f ). Endocardial Gpr126 expression, the trabecular phenotype of Gpr126 mutant mice 21, 22 , and Gpr126 downregulation in mouse and zebrafish Notch mutants suggest that it as a Notch target during trabeculation. To substantiate the relationship between Notch and Gpr126, we conducted real-time quantitative PCR with reverse transcription (qRT-PCR) on Dll4-stimulated HUVEC. Dll4 increased Gpr126 expression, an effect abolished by RO4929097 ( Supplementary  Fig. 2g ). In silico analysis revealed two conserved putative RBPJKbinding sites in Gpr126 intron four. Luciferase reporter assays in bovine aortic endothelial cells (BAEC) showed that increasing amounts of N1ICD were able to transiently activate the Gpr126 reporter fivefold (Supplementary Fig. 2h ).
Adult heart function requires signalling from myocardial Jag1 to endocardial Notch1
Jag1 inactivation with the early myocardial driver cTnT-Cre (ref. 24) did not affect trabeculation ( Supplementary Fig. 5a ); moreover, despite efficient deletion of Jag1 flox in the ventricles, N1ICD expression was unaffected in E10.5 Jag1 flox ;cTnT-Cre mice ( Supplementary Fig. 5a,b) . Similarly, expression of Hey2, EfnB2, Nrg1 and Bmp10 seemed normal ( Supplementary Fig. 5c ). Jag1 thus seems not to be required for trabeculation and Notch1 activation in the early ventricle. In E13.5 Jag1 flox ;cTnT-Cre embryos, myocardial Jag1 expression is abrogated and endocardial N1ICD expression is markedly reduced (Supplementary Fig. 5d ), indicating
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Venus-SMA-CD31-DAPI (n = 10 WT and n = 9 mutants at 6 months and n = 11 WT and n = 10 mutants at 9 months, * P < 0.05 and * * P < 0.01 by Student's t-test). (j) CMRI analysis of physiological and morphometric parameters in the left (LV) and right ventricles (RV) of 6-month-old WT and Jag1 flox ;cTnT-Cre mice. EF, ejection fraction; ES mass, end-systolic mass; ED volume, end-diastolic volume. Data are mean ± s.e.m. (n = 7 WT and n = 7 mutants, * P < 0.05 and * * P < 0.01 by Student's t-test; NS, not significant). that at this stage Notch1 activity in the ventricles depends on Jag1 signalling. E16.5 WT embryos had a thick compact myocardium and compacting trabeculae, whereas Jag1 flox ;cTnT-Cre embryos revealed a 21% thinner compact myocardium in the right ventricle (Fig. 2a-b ,g ). Mutant embryos also showed 30% and 42% higher trabecular complexity in the left and right ventricles (Fig. 2g) . Increased trabecular complexity is a hallmark of LVNC and hypertrophic cardiomyopathies 25 . WT neonates had thick muscular ventricular walls (Fig. 2c,c ) , but Jag1 flox ;cTnT-Cre littermates had dilated ventricles and a thin compact myocardium (Fig. 2d,d ). These defects were also apparent in mutant adult heart (Fig. 2e-f ) . Ultrasonography revealed impaired left ventricular systolic function in adult Jag1 flox ;cTnT-Cre mutants, with reductions in ejection fraction, fractional shortening and diastolic interventricular septal wall thickness (Fig. 2h,i and Supplementary Video 2). High-resolution cardiac magnetic resonance imaging (CMRI) confirmed ventricular wall thinning in Jag1 flox ;cTnT-Cre animals ( Fig. 2h and Supplementary Video 3). CMRI also revealed reductions in left ventricular ejection fraction, cardiac output, end-systolic mass, end-diastolic volume and the thickness of right ventricular free wall (Fig. 2j) , which also showed segmental dyskinesia (Supplementary Video 4).
Jag1 is required for ventricular maturation
Chamber marker analysis in E16.5 Jag1 flox ;cTnT-Cre embryos revealed expansion of the compact myocardium marker Hey2 to the trabeculae ( Table 1) . GO classification revealed involvement in essential cellular functions, cardiovascular development and disease, and dilated cardiomyopathy (Fig. 3b) . E16.5 Jag1 flox ;cTnT-Cre mutants showed strong downregulation of the chemokine ligand gene Cxcl12 (Fig. 3b ,c and Supplementary  Table 1) , with attenuated chamber myocardium expression at E16.5 ( Fig. 3d-e ) . Interestingly, Cxcl12/Cxcr4 signalling is crucial for coronary artery development 26, 27 , a process simultaneous with and essential for compaction 28 . One upregulated gene was the cellcycle inhibitor Cdkn1a/p21 ( Fig. 3b and Supplementary Table 1) . Consistent with RNA-seq, p21 expression was 30% above normal in E13.5 Jag1 flox ;cTnT-Cre mutant ventricles ( Fig. 3f -g ,n) concomitantly with reductions in compact myocardium proliferation (56%) and endocardial N1ICD expression (28%; Fig. 3h -i ,n). This defect persisted at E16.5 when Jag1 flox ;cTnT-Cre embryos had a 25% below-normal proliferation of compact myocardium cardiomyocytes ( Fig. 3j-k ,n) . In situ hybridization (ISH) and qRT-PCR in E16.5 Jag1 flox ;cTnT-Cre mutants revealed reduced Gpr126 transcription (Fig. 3c ,l-m ), similar to the situation in Dll4 mutants ( Fig. 1p-q ) .
Jag2 is required for chamber maturation and compaction together with Jag1
Targeted Mib1 inactivation in mouse myocardium causes LVNC cardiomyopathy 15 . We expected similar cardiac phenotypes in Mib1 flox ;cTnT-Cre and Jag1 flox ;cTnT-Cre mutants, assuming Jag1 as the only myocardial ligand and therefore the only potential Mib1 substrate. This was not the case: E16.5 Jag1 flox ;cTnT-Cre mutants showed a thin compact myocardium and altered ventricular patterning, and adult mutants showed structural and functional signs of cardiomyopathy and systolic dysfunction, but not LVNC (Fig. 2) . The phenotypic differences between Mib1 and Jag1 mutants suggested that another Notch ligand might be acting in the myocardium.
Myocardial expression of Jag2, a mammalian Jag1 paralogue, was upregulated from E10.5, (Fig. 4a) . Jag2 upregulation paralleled Jag1 downregulation so that at E12.5-14.5 Jag1 and Jag2 expression levels were similar, with Jag2 levels higher thereafter (Fig. 4a) . E16.5 Jag2 flox ;cTnT-Cre mice showed strongly diminished Jag2 expression in myocardium (Fig. 4a) , and had a poorly structured ventricular septum and a 38% thinner compact myocardium, paralleled by a 20% increase in trabecular complexity (Fig. 4b-c ,e) . Compact myocardium thinning was most likely due to the 30% reduced cardiomyocyte proliferation at E13.5, especially in the right ventricle ( Fig. 4f ,g,l). Consistent with action of Jag2 as a cardiac Notch ligand, N1ICD expression was 35% reduced in the right ventricle of E16.5 Jag2 flox ;cTnT-Cre embryos (Fig. 4i ,j,l), indicating that myocardial Jag2 deletion disrupted endocardial Notch activation. Furthermore, Hey2, Bmp10 and Gpr126 were downregulated in Jag2 flox ;cTnT-Cre mutants ( Fig. 4m-r) .
We next generated mice doubly deficient for myocardial Jag1 and Jag2. E16.5 Jag1 flox ;Jag2 flox ;cTnT-Cre embryos have a very thin compact myocardium, especially the ventricular apex region (Fig. 4d,d ) , with a 27% thinner compact myocardium overall ( Fig. 4e and Supplementary Fig. 6a ). In contrast, trabecular complexity and trabecular area were respectively 26% and 72% above normal in the right ventricle of Jag1 flox ;Jag2 flox ;cTnT-Cre mice ( Fig. 4e and Supplementary Fig. 6a ), indicating defective compaction. Immunostaining of E16.5 Jag1 flox ;Jag2 flox ;cTnT-Cre heart sections for cTnT and endomucin, to label the myocardium and endocardium, showed a severe chamber phenotype ( Supplementary Fig. 7a-b ) , reminiscent of Mib1 flox ;cTnT-Cre mice 15 . Cardiomyocyte proliferation in E13.5 Jag1 flox ;Jag2 flox ;cTnT-Cre compact myocardium was 40% below normal in both ventricles (Fig. 4f ,h,l). Endocardial Notch1 activity was also significantly reduced (32%, Fig. 4i ,k,l). Hey2 delineated a thin compact myocardium with deep recesses (see below), Bmp10 was expressed in the trabeculae and endocardial Gpr126 expression was attenuated ( Fig. 4m-o ,s-u). Jag1 and Jag2 thus seem to play non-redundant roles in chamber development.
Manic Fringe modulates Notch ligand selectivity in ventricular endocardial cells
The Fringe family of glycosyltransferases elongate carbohydrates attached to the Notch extracellular EGF-like repeats, contributing to ligand selectivity 29 . On Notch glycosylation, Delta-Notch signalling is enhanced, and Jag/Ser-Notch signalling is diminished 29, 30 . We first examined embryonic cardiac expression of the three mammalian Fringe paralogues by ISH and qRT-PCR. Manic fringe (MFng ) was transcribed in chamber endocardium from E8.5, subsequently declining to a minimum at E11.5 ( Fig. 5a,b) . In contrast, lunatic fringe (LFng ) was transcribed in epicardium and radical fringe (RFng) was not detected in the heart (Supplementary Fig. 8a,b) . ISH data for MFng suggested that MFng activity in E8.5-10.5 chamber endocardium 
A R T I C L E S
S tm n1 (n = 6 WT and 6 mutant embryos, except for E16.5 BrdU quantification, where n = 3 WT and n = 3 mutant embryos; * * P < 0.01, by Student's t-test). Abbreviations as in Fig. 2 . Scale bars, 100 µm. Source data are available in Supplementary Table 4 . Myocardial Jag2, together with Jag1, is required for ventricular maturation and compaction. (a) ISH of Jag2 in heart sections from E10.5, E12.5, E14.5, E16.5 WT and E16.5 Jag2 flox/flox ;cTnT-Cre/ + (Jag2 flox ;cTnT-Cre) embryos. Abbreviations as in Fig. 1 . cTnT-Cre-mediated deletion abrogates Jag2 expression in the myocardium but does not affect expression in coronary vessels (arrowheads). Chart shows relative ratios of Jag1 and Jag2 gene expression measured by qRT-PCR. Data are means ± s.d. (n = 3 pools of 3 WT ventricles per pool for each stage analysed; * * P < 0.01, * * * P < 0.001, by Student's t-test; NS, not significant). (n = 9 sections from 3 WT and n = 9 sections from 3 Jag2 flox ;cTnT-Cre; n = 12 sections from 4 WT and n = 12 sections from 4 Jag1 flox ;Jag2 flox ;cTnT-Cre embryos; * * P < 0.01, * * * P < 0.001, determined by Student's t-test; NS, not significant). (f-h) BrdU (green) and SMA (red) immunostaining in E13.5 WT (f), Jag2 flox ;cTnT-Cre (g) and Jag1 flox ;Jag2 flox ;cTnT-Cre hearts (h). Nuclei are counterstained with DAPI (blue). (i-k) N1ICD immunostaining. In the E16.5 WT heart (i), N1ICD (red) labels endocardial nuclei (yellow arrowheads) delineated by endomucin staining (green), and coronary vessels (white arrowheads). Jag2 flox ;cTnTCre (j) and Jag1 flox ;Jag2 flox ;cTnT-Cre hearts (k) show below-normal N1ICD expression. (l) Quantification of BrdU-and N1ICD-positive cells in both genotypes. Data are mean ± s.d. (n = 3 WT and n = 3 Jag2 flox ;cTnT-Cre for BrdU and N1ICD stainings; n = 3 WT and n = 4Jag1 flox ;Jag2 flox ;cTnTCre embryos for BrdU and N1ICD analyses; * P < 0.05, * * P < 0.01, by Student's t-test; NS, not significant). would favour endocardial Dll4 signalling to the Fringe-modified Notch receptor. We investigated the effect of MFng on ligand stimulation of Notch1, using isolated and immortalized mouse embryonic ventricular endocardial cells (MEVEC) transduced with lentiviral vector encoding MFng (MFng -MEVEC). We first examined the response of control GFP-MEVEC to stimulation with immobilized recombinant Dll4, Jag1 or Jag2 ligands 31 . As readouts we measured the activity of the Notch reporter CBF1-Luc (ref. 32 ; Fig. 5c ) and transcript expression of endocardial Notch target Hey1 (ref. 33; Fig. 5d ). Dll4 and Jag1 activated the Notch reporter to a similar extent, whereas Jag2 elicited a weaker response (Fig. 5c ), but all three ligands induced a similar increase in Hey1 expression (Fig. 5d) . Pairwise ligand combinations produced additive effects (Fig. 5c) . In MFng -MEVEC Notch reporter activity and Hey1 expression were potentiated by Dll4, whereas the response to Jag1 and Jag2 remained weak (Fig. 5c,d) . Combinations of Dll4+Jag1 and Dll4+Jag2 produced a similar response to stimulation with Dll4 alone (Fig. 5c,d ), but the Jag1+Jag2 combination stimulated Notch signalling weakly (Fig. 5c,d ).
Systemic Fng inactivation affects coronary vessel development
Our data suggest that MFng may regulate the spatio-temporal specificity of Notch ligand-receptor interaction in the developing chamber. In E8.5-10.5 chamber endocardium, MFng would favour endocardial Dll4 signalling to the Fringe-modified Notch receptor. MFng downregulation after E11.5 would allow Jag1 and Jag2 myocardial signalling to activate endocardial Notch1. We examined the effect of systemic Fng inactivation by generating mice triply deficient for M, L and RFng. Triple mutants develop to term and, although not found at Mendelian frequency at weaning, there are no reported embryonic lethal phenotypes 34 . Examination of M;L;RFngdeficient embryos at E10.5 revealed no obvious trabeculation defects, suggesting that Dll4 (and Jag1) is able to activate Notch signalling sufficiently. At E16.5, WT chamber development is well advanced (Fig. 5e,e ) ; R −/− embryos had a 33% thinner compact myocardium (Fig. 5f,f ,k) ; moreover, CD31 staining revealed coronary vessel loss or defects (Fig. 5g,h) . Interestingly, N1ICD expression seemed normal in ventricular endocardium but was attenuated in coronary vessels (Fig. 5i-j ) . Hey2 expression marked the thin compact myocardium and Cx40 was expressed in trabeculae but did not label (Fig. 5l) . Coronary arteries of E16.5 Fng -deficient embryos also showed abnormal expression patterns of Dll4, Hey1, HeyL and EfnB2 (Fig. 5m) , similar to E15.5 Dll4 flox ;Cdh5-Cre ERT mutant hearts ( Supplementary Fig. 3k-p ) . Systemic Fng abrogation disrupts coronary vessel development, crucial for myocardium nourishment, thus indirectly affecting compaction. During compaction MFng is expressed in coronary vessels (Fig. 6a) , similarly to Dll4 (Supplementary Figs 1e,e and 3e,e ) suggesting that MFng may reinforce Dll4 signalling to Notch in the developing coronaries.
Forced MFng expression disrupts chamber development and compaction
Our in vitro data predicted that forced endocardial MFng expression would hamper Jag1-and Jag2-mediated Notch1 activation, producing a chamber phenotype similar to that caused by inactivation of both ligands (Fig. 4d,d and Supplementary Fig. 7b-b ) or Mib1 inactivation ( Supplementary Fig. 7d-d and ref. 15 ). We generated a transgenic line (MFng tg ) bearing a Rosa26-CAG-floxNeoSTOPfloxMFng-EGFP expression cassette (Fig. 6b) . Tie2-Cre-mediated 18 removal of the NeoSTOP sequences resulted in Rosa26-CAG-driven MFng-EGFP expression in vascular endothelium and endocardium (Fig. 6b,c,c ) . At E16.5, transgenic mice with two MFng-EGFP copies had a dilated heart, with compact myocardium 50-60% thinner than WT (Fig. 6d,e,r and Supplementary Fig. 7c-c ) , whereas trabecular complexity and trabecular area were 30% and >300% above normal (Supplementary Fig. 6a ), indicating defective compaction. Cardiomyocyte proliferation was 38% impaired in compact myocardium of E13.5 transgenic embryos (Fig. 6f,g,s) . Unlike the thick compact myocardium with some compacting trabeculae in WT neonate mice (Fig. 6h-h ) , MFng tg ;Tie2-Cre neonates had thin compact myocardium and non-compacted trabeculae in both ventricles, with no effect on cardiomyocyte size (Fig. 6i-i ) . N1ICD expression was impaired in the ventricles of E16.5 MFng tg ;Tie2-Cre mice ( Fig. 6j-k ,t) , indicating that forced MFng endocardial expression disrupts Notch activation.
Hey2 expression in E16.5 MFng tg ;Tie2-Cre mice delineated the thin compact myocardium and extended towards but did not reach the trabeculae tip (compare Fig. 6l,m) , whereas Bmp10 and Cx40 were restricted to the distal trabeculae tip (compare Fig. 6n-q) . Indeed, Hey2 and Bmp10 (or Cx40) expression in the trabeculae were complementary (compare Fig. 6m,o,q) . In the MFng tg ;Tie2-Cre ventricle, compact myocardium cardiomyocytes (Hey2 + , Fig. 6m ) seemed to enter the trabeculae and form an 'intermediate myocardium' (Hey2 Fig. 6m ) defining a boundary between compact and trabecular myocardium (Hey2 − , Bmp10 + , Cx40 + , Fig. 6o,q) . A similar but more subtle phenotype was observed in Jag2 flox ;cTnT-Cre and Jag1 flox ;Jag2 flox ;cTnTCre hearts (Fig. 4m ,n,p,q,s,t) but not Mib1 flox ;cTnT-Cre hearts 15 . Upregulated MFng expression in coronary endothelium (Fig. 6a) and loss of Cx40 expression in coronaries of E16.5 MFng tg ;Tie2-Cre mice (Fig. 6q) suggests that ectopic MFng might also affect compaction through alteration of the development of coronaries.
Comparative gene profiling
RNA-seq of E15.5 WT, Jag2 flox ;cTnT-Cre, Jag1 flox ;Jag2 flox ;cTnT-Cre and MFng tg ;Tie2-Cre hearts was performed and compared with those from Jag1 flox ;cTnT-Cre ( Fig. 3 (Fig. 7b) . The heat map in Fig. 7c shows the 319 genes differentially expressed in at least two of the five mutant genotypes. Jag2 inactivation affected fewer genes (41) than Jag1 (97), but many more and coronaries (j , white arrowhead) and very attenuated in the transgenic heart (k ). (l-q) ISH. Hey2 expression reveals a thick compact myocardium in the E16.5 WT heart (l) and a very thin and disorganized counterpart in the MFng tg ;Tie2-Cre heart (m). Bmp10 and Cx40 label ventricular trabeculae in WT embryos (n,p) and both are expressed at the distal tip of trabeculae in MFng tg ;Tie2-Cre embryos (o,q, arrows). Cx40 is also expressed in WT coronaries (p, white arrow) but not in transgenic embryos (q). The arrowhead (m,o,q) marks the transition between Bmp10 − ,Cx40 − and Bmp10 + ,Cx40 genes were affected in the double Jag1 flox ;Jag2 flox ;cTnT-Cre mutant (474), indicating a synergistic effect of simultaneous inactivation (Fig. 7c) . MFng tg ;Tie2-Cre mice presented the largest number of deregulated genes, and genes shared with Jag1 flox ;Jag2 flox ;cTnT-Cre mutants generally changed in the same direction (Fig. 7c) . The profile of Mib1 flox ;cTnT-Cre mutants was different, with expression of several deregulated genes showing the opposite changes to Jag1 flox ;Jag2 flox ;cTnT-Cre or MFng tg ;Tie2-Cre mice (Fig. 7c ). GO analysis (Fig. 7d and flox ;Jag2 flox ;cTnT-Cre and MFng tg ;Tie2-Cre mice. A second GO category included cell-cycle and proliferation genes, in which negative cell-cycle regulators (Cdkn1a/p21, Plk2, Rps6ka2 and Romo1) were upregulated in all genotypes except Mib1 flox ;cTnT-Cre mice (Fig. 7d) . These results fit with the reduced cardiomyocyte proliferation in Jag1 and Jag2 mutants (Figs 3n and 4l) but not Mib1 flox ;cTnT-Cre mice 15 ( Supplementary Fig. 6b-d ) . Cell-death-related genes were deregulated in Jag2 flox ;cTnT-Cre, Jag1 flox ;Jag2 flox ;cTnT-Cre and MFng tg ;Tie2-Cre hearts, including the apoptosis inhibitors Spp1, Bcl6, Prnd and Bcl2l11 (downregulated) and the pro-apoptotic gene Cish (upregulated), suggesting altered cardiac cell homeostasis. Similar to what was found in Dll4 flox and Notch1 flox mutants (Fig. 1l) , Semaphorin and Ephrin-Eph family members involved in cellular motion, axonal guidance and migration were deregulated. Semaphorins play key functions in cardiac morphogenesis and vascular patterning 40, 41 . One downregulated gene, Efnb3, is associated with the cardiac hypertrophic response in adult heart 42 . Genes related to dilated, hypertrophic and arrhythmogenic right ventricular cardiomyopathy (DCM, HCM and ARVC) were deregulated in Jag1 flox ;cTnT-Cre, Jag1 flox ;Jag2 flox ;cTnTCre, MFng tg ;Tie2-Cre and Mib1 flox ;cTnT-Cre mice. Genes required for heart morphogenesis (Nkx2.5, Adamts1, Smad7, Gaa and Eng ) were upregulated in Jag1 flox ;Jag2 flox ;cTnT-Cre mutants, whereas Bmp10 and ErbB4 expression changed in opposite directions in MFng tg ;Tie2-Cre and Mib1 flox ;cTnT-Cre mice. Last, a set of genes encoding voltage-dependent potassium and calcium channels (Kcnd3, Kcne1, Kcne3, Kcnd2 and Cacna1g ) was deregulated in Jag1 flox ;cTnT-Cre, MFng tg ;Tie2-Cre and Mib1 flox ;cTnT-Cre mice.
DISCUSSION
Our studies demonstrate that heart chamber development is coordinated through sequential Notch1 receptor activation in the endocardium, first by endocardially expressed Dll4 and later by Jag1 and Jag2 signalling from the myocardium. This temporally patterned Notch1 activation is determined by MFng and elicits different morphogenetic processes in the developing ventricles: the early, MFng-favoured endocardial Dll4-Notch1 signalling promotes cardiomyocyte proliferation and differentiation leading to trabeculation. The late, myocardial Jag1/Jag2-endocardial Notch1 signalling, occurring after MFng (and Dll4) downregulation in the endocardium, supports myocardial patterning, maturation and compaction. Simultaneously, coronary endothelial Dll4 signalling to the Fngmodified-Notch1 receptor stimulates coronary vessel development. RNA-seq of endocardial-specific Dll4 or Notch1 mutant hearts shows deregulation of a set of genes involved in crucial cellular processes, signalling, cardiovascular development and disease. Gpr126 is of particular interest because its expression is dependent on Notch signalling in endothelial cells, zebrafish and mouse. Moreover, targeted Gpr126 inactivation in mice disrupts trabeculation, revealing its crucial function in chamber development 22 . Work in zebrafish showed that an amino-terminal Gpr126 fragment rescues the trabeculation phenotype of gpr126 morphants 22 , suggesting that this fragment can function as a paracrine signal instructing adjacent trabecular cardiomyocytes. In response to Notch, Gpr126 might influence the proliferation and differentiation of neighbouring cardiomyocytes within the developing chamber. Accordingly, cardiomyocyte proliferation, essential for ventricular growth, is affected in endocardial Dll4 and Notch1 mutants. Indeed, we reported defective cardiomyocyte proliferation in RBPJk/CBF1 mutants, accompanied by reduced Bmp10 expression 12 . RNA-seq revealed increased expression of various negative cell-cycle regulators, suggesting that Notch signalling plays a general role in regulating cardiomyocyte proliferation. Proliferation and differentiation of embryonic cardiomyocytes are intimately connected 43 and our data suggest that Notch regulates both processes. Gene profiling revealed no significant changes in EfnB2 or Nrg1, despite their downregulation after endothelial Dll4 deletion in the ISH analysis and their roles downstream of Notch during trabeculation 12 . This discrepancy might reflect the low expression of EfnB2 and Nrg1 in WT heart and the strict criteria for considering a gene-expression change as significant. Jag1 is non-essential for trabeculation but is required for ventricular maturation. Jag1 inactivation in embryonic myocardium generated mice with a dilated heart, a thin compact myocardium, reduced ejection fraction and cardiomyopathy with systolic dysfunction. Myocardium-specific Jag1 mutants showed impaired proliferation and elevated p21 expression in compact myocardium cardiomyocytes, findings supported by the RNA-seq. Expression of various chamberpatterning markers was also impaired, indicating that Jag1 is required for ventricular patterning and maturation. Myocardial Jag1 mutants, like endocardial Dll4 mutants, showed reduced Gpr126 expression, indicating Gpr126 as an important Notch effector throughout chamber development. Myocardial expression of Jag2 increases from E12.5, mirroring Jag1 expression. Jag2 deletion also disrupts chamber maturation, and combined Jag1 and Jag2 deletion triggers a severe chamber phenotype reminiscent of LVNC.
MFng is a crucial temporal modulator of Notch ligand-receptor interaction during ventricular development. In vitro experiments show that in the absence of MFng, Dll4, Jag1 and Jag2 activate Notch to similar levels and that pairwise combinations of these ligands have an additive effect. In the presence of MFng, Dll4 becomes a Notch1 superactivator, but Jag1 and Jag2 activate Notch1 quite poorly, and do not affect the response to Dll4. The function of MFng as a Notch modulator has been described in embryonic (1) endocardial Dll4 and myocardial Jag1 can activate Notch1 in the endocardium. Expression of MFng in the endocardium favours Dll4 signalling to Notch1 (large green arrow) and Jag1 signalling is low (small blue arrow). Notch1 activation (red) promotes cardiomyocyte proliferation, trabecular growth and patterning. As chamber development proceeds (2), endocardial MFng expression reduces progressively (similarly to Dll4) allowing myocardial Jag1 to activate Notch1 in the myocardium. Jag2 expression is progressively upregulated in chamber myocardium, where it acts together with Jag1 to promote chamber proliferation, patterning and trabecular compaction to give rise to the functional ventricular wall (large blue arrow). At this time, MFng and Dll4 are required for Notch1 activation in coronary vessels (small green arrow). Inactivation of Jag1 (or Jag2) in the myocardium disrupts chamber maturation and leads to cardiomyopathy. Mib1 acts upstream of Jag1 and Jag2 in this process: Mib1 inactivation in the myocardium causes LVNC. A similar phenotype is produced when both Jag1 and Jag2 are deleted in the myocardium and when MFng is constitutively expressed in the endocardium (presumably causing persistent inhibition of Jag1 and Jag2 signalling). LOF, loss of function.
vasculature, where Jag1 is co-expressed with Dll4 in endothelial cells and inhibits Notch activation 31 . In the developing ventricle the situation is different because Dll4 and Jag1 are expressed in different cell types. This MFng-Dll4-Notch1 relationship also exists in the coronaries, as indicated by our loss-of-function data showing that MFng and Dll4 are required for coronary vessel development and thus indirectly for compaction. Ectopic MFng overexpression in vascular endothelium and endocardium of MFng tg ;Tie2-Cre mice causes a severe, LVNC-like chamber phenotype. RNA-seq identified a large set of differentially expressed genes overlapping those affected in Jag1 flox ;Jag2 flox ;cTnT-Cre mice. Thus, the data indicate that MFng overexpression throughout the endocardium effectively blocks Jag1 and Jag2 myocardial signalling to Notch1.
The chamber-patterning defects in Jag2 flox ;cTnT-Cre, Jag1 flox ; Jag2 flox ;cTnT-Cre and MFng tg ;Tie2-Cre mice are emphasized by the detection of an 'intermediate myocardium' (Hey2 + ) in the trabeculae, proximal to the thin compact myocardium (Hey2 + ), in addition to the distal trabecular myocardium (Hey2 − ,Bmp10 + , Cx40 + ). Supplementary Fig. 7 illustrates a feature common to all Notch mutants affecting compaction analysed here or previously 15 :
the structural chamber defects are more severe in the right ventricle, perhaps reflecting the different developmental origins of the ventricular chambers 44 . Our results are summarized in Fig. 8 . Inactivation of the ubiquitin ligase MIB1 causes LVNC in mice and humans 15 . The current findings show that combined myocardial inactivation of Jag1 and Jag2 also causes LVNC, suggesting that both ligands are Mib1 substrates in the myocardium. This is supported by the LVNClike phenotype after forced endocardial MFng expression (Fig. 8) . Our findings shed light on the molecular mechanisms orchestrating ventricular chamber development, and the coordination between compaction and the formation of the coronary vessels that nourish the mature ventricles. Understanding these developmental processes has important implications for the management of heart disease.
METHODS
Methods and any associated references are available in the online version of the paper. 34 . For the generation of Rosa26-MFng Tg mice (Acc. No. CDB0917K: http:// www.cdb.riken.jp/arg/mutant%20mice%20list.html), a cDNA encoding a native form of murine MFng was cloned into a modified version of the pROSA26-1 vector, preceded by the ubiquitous CAG promoter and a loxP-flanked 'Neo R -STOP' cassette and followed by a frt-flanked IRES-EGFP cassette and a bovine polyadenylation sequence. Gene targeting was done with TT2 embryonic stem cells and confirmed by Southern blotting. Mice were generated by injection of targeted embryonic stem cells into ICR embryos, and were backcrossed with the C57BL/6 strain. Details of genotyping will be provided on request.
Zebrafish experiments. Zebrafish were maintained and raised under standard conditions at 28 • C. We used WT AB and mib ta52b fish 51 . WT embryos were treated for 15 h with RO4929097 (S1575, selleckchem.com, 10 µM) or with dimethylsulphoxide 23 (DMSO). All embryos were fixed at 48 hpf in 4% PFA overnight and processed for in situ hybridization (ISH) as described previously 52 .
4-hydroxy-tamoxifen (4-OHT) induction. Dll4
flox/+ ;Cdh5-Cre ERT /+ male mice were crossed with Dll4 flox/flox females and pregnant females were administered with 4-OHT (H6278 Sigma) once by oral gavage at 12.5 days of gestation. Embryos were dissected at E15.5.
Histology and in situ hybridization. Haematoxylin-eosin (H&E) staining, in situ hybridization (ISH) on sections, and whole-mount ISH were performed as described previously 52, 53 . Details of probes will be provided on request.
Whole-mount immunofluorescence. E9.5 CBF:H2B-Venus embryos were dissected and fixed for 2 h in 4% PFA at 4 • C. Embryos were permeabilized for 1 h with 0.5% Triton X-100/PBS and subsequently blocked for 1 h in Histoblock solution (5% goat serum, 3% BSA, 0.3% Tween-20 in PBS). Primary and secondary antibodies used are listed in Supplementary Table 2 . After several washes in PBS-T (PBS containing 0.1% Tween-20) embryos were mounted in a 60 mm Petri dish with 1% agar. To detect endogenous GFP, fixed E9.5 CBF:H2B-Venus; CBF:H2B-Venus;N1KO and CBF:H2B-Venus;RBPJkKO embryos were imaged with a Zeiss 780 confocal microscope fitted with a ×20 objective with a dipping lens. Z-stacks were taken every 5 µm. 3D images were reconstructed with IMARIS software (Bitplane Scienific Software).
Immunohistochemistry. Paraffin sections (7 µm) were incubated overnight with primary antibodies, followed by 1 h incubation with a fluorescent-dyeconjugated secondary antibody. N1ICD, Dll4, Jag1 and p21 staining was performed using tyramide signal amplification 54, 55 (TSA). All antibodies used are listed in Supplementary Table 2 .
Quantification of incorporated BrdU, p21 and N1ICD. Cell proliferation was analysed by detection of BrdU incorporation 55 . For p21 and N1ICD quantification, positive nuclei were divided by the total number of nuclei counted on sections (≥4) in six embryos of each genotype. Images were processed with ImageJ software. Statistical significance was assessed by Student's t-test.
Quantification of compact myocardium thickness and trabecular complexity.
The method used was a modification of that described in refs 56,57. Briefly, 7 µm paraffin sections from E9.5 WT and mutant hearts were stained with anti-CD31 and anti-MF20 to facilitate visualization of ventricular structures. In E16.5 WT and mutant hearts endocardial cells were stained with anti-endomucin and myocardium with anti-cTnT. Confocal images were obtained with a NIKON A1R confocal microscope. ImageJ software was used for the measurements. In E16.5 heart sections, left and right ventricles were analysed separately. For each measurement, settings were kept constant for all images using the scale bar recorded in each image as the reference distance. The thickness of the compact myocardium was measured by dividing the ventricle into two main regions: the apex (at the bottom of a transverse section) and the basal region (at the top; see Supplementary  Fig. 7a ). Several measurements were taken in each region and the mean was expressed in micrometres. The complexity of trabecular myocardium indicates the size of the trabecular mesh of myocardial fibres and is considered a landmark of cardiomyopathy 25 . It was represented as the mean ratio, expressed in micrometres, obtained by dividing the length of each trabecula by its thickness. The ratio of trabecular area and compact myocardial thickness was measured by dividing the surface occupied by trabeculae in the ventricle (µm 2 ) by the length of compact myocardium expressed in micrometres.
Imaging, photography and 3D reconstruction. E9.5 whole-embryos or hearts were imaged with a Zeiss 780 confocal microscope fitted with a ×20 objective with a dipping lens. Z-stacks were taken every 5 µm. 3D images were reconstructed with IMARIS software (Bitplane Scientific Software). WT E9.5 embryos were sectioned at 10 µm and stained for Dll4, Jag1 and N1ICD. Images were acquired with a confocal microscope (Leica TCS SPE) taking 10 optical sections per histological section. After acquisition, 3D reconstructions were performed as described previously 58 and the resulting surfaces were exported to Adobe Acrobat Professional 9 Extended version to generate 3D interactive pdf files 59 . flox ;Tie2-Cre embryos (27 per genotype). RNA was pooled into four replicates for the first genotype pairs and three replicates for the last two genotype pairs. For Jag1 flox ;cTnT-Cre hearts, RNA was isolated from the ventricles of 12 WT and 12 mutant hearts at E15.5 and then pooled into three replicates. RNA was prepared using the standard Illumina TrueSeq RNA-Seq library preparation kit. Libraries were sequenced in a GAIIx Illumina sequencer using a 75 bp single end elongation protocol. For Jag2 flox ;cTnT-Cre and Jag1 flox ;Jag2 flox ;cTnTCre hearts, RNA was isolated from the ventricles of 8 WT and 12 mutant hearts at E15.5 and then pooled into two and three replicates respectively. For MFng GOF ;Tie2-Cre hearts, RNA was isolated from the ventricles of 16 WT and 16 GOF hearts at E15.5 and then pooled into four replicates each. RNA was prepared using the NEBNext Ultra RNA Library Prep Kit for Illumina. Libraries were sequenced in a HiSeq2500 Illumina sequencer using a 61 bp single end elongation protocol. Sequenced reads were QC and pre-processed using cutadapt v1.6 (ref. 61 ) to remove adaptor contaminants. Resulting reads were aligned and gene expression quantified using RSEM v1.2.3 (ref. 62) over mouse reference GRCm38 and Ensembl genebuild 70. Gene differential expression was analysed using the EdgeR R package 63 . Data from Dll4 flox ;Tie2-Cre and Dll4 flox ;Nfatc1-Cre experiments were analysed together, as were data from Dll4 flox ;Nfatc1-Cre and Notch1 flox ;Nfatc1-Cre experiments, by applying batch correction using ComBat (ref. 64 ) to account for experimental differences. For Jag1 flox and Jag2 flox single and double Jag1 flox ;Jag2 flox ;cTnT-Cre experiments, data were analysed together applying batch correction to account for technical differences and adding the genotypes of both alleles as covariates. Mib flox ;cTnT-Cre (E14.5) RNA-Seq from ref. 15 was reanalysed using the GRCm38 genebuild 70 reference. Genes showing altered expression with adjusted P < 0.05 were considered differentially expressed. For the set of differentially expressed genes a functional analysis was performed using Ingenuity Pathway Analysis Software and DAVID (ref. 65) , and some of the enriched processes were selected according to relevant criteria related to the biological process studied. Unsupervised hierarchical clustering with Genesis Software 66 was used to group genes according to the similarity of their expression profiles across the different Dll4 and Notch1 deficiency experiments. Using a new R visualization package called GOPlot, a chord plot 67, 68 was generated to better visualize the relationships between genes and the selected enriched processes.
Accession number. Data are deposited in the NCBI GEO database under accession number GSE67889.
Ultrasound. Left ventricle (LV) function and wall thickness were analysed by transthoracic echocardiography in male mice at 6 and 9 months of age. Mice were mildly anaesthetized by inhalation of isoflurane/oxygen (1-2%/98.75%) adjusted to obtain a target heart rate of 450 ± 50 beats per minute and examined with a 30 MHz transthoracic echocardiography probe. Images were obtained with Vevo 2100 (VisualSonics) from Jag1 flox ;cTnT-Cre, Jag2 flox ;cTnT-Cre and WT littermates. LV long-axis M-Mode views were obtained as described previously 69 . From these images, interventricular septum end-diastolic thickness was measured, and LV systolic function was assessed by estimating LV shortening fraction and LV ejection fraction 69 .
Cardiac MRI. Six-month-old male mice were anaesthetized by inhalation of isoflurane/oxygen (2%) and monitored by ECG and breathing rhythm (Model 1025, S.A. Instruments). Images were acquired with an Agilent/Varian 7 T system equipped with a DD1 console and an active shielded 205/120 gradient insert coil with 130 mT m −1 maximum strength and a combination of volume (transmission, TX) and two-channel phased array (reception, RX) coils (Rapid Biomedical GmbH) for transmit/receipt. Data were collected in a triggered cine gradient echo sequence with TE = 1.45 ms and TR = 7 ms, FA 25 • , 20 cardiac phases, and NA (number of averages) = 3. A total of 13 contiguous slices in the short-axis view were acquired, with a slice thickness of 0.8 mm. The field of view was 3 × 3 cm, with a 256 × 256 matrix. Left ventricle (LV) and right ventricle (RV) function, end-diastolic volume, mass and wall thickness of the right ventricle were estimated by the Simpson method, which sums the RV end-diastolic areas from the 13 slices in the short-axis view and multiplies this figure by the 0.8 mm slice thickness. Images were processed using OsiriX (Pixmeo) and Medis MASS software (The Netherlands) to calculate every RV area by segmentation of end-diastolic epicardial and endocardial edge 70 .
Statistical analysis. Statistical analysis was carried out using Prism 5 (GraphPad).
All statistical tests were performed using two-sided, unpaired Student's t-tests except for Fig. 2j where numerical data are presented as mean ± s.e.m; * P < 0.05, * * P < 0.01 and * * * P < 0.001. Sample size was chosen empirically according to previous experience in the calculation of experimental variability. No statistical method was used to predetermine sample size. All experiments were carried out with at least three biological replicates. The numbers of animals used are described in the corresponding figure legends. For adult image analysis by echo and CMRI we ensured that experimental groups were balanced in terms of animal age, sex and weight unless otherwise specified. Animals were genotyped before the experiment and were caged together and treated in the same way. Variance was comparable between groups throughout the manuscript. We chose the appropriate tests according to the data distributions. The experiments were not randomized. 
